One of two receptor tyrosine kinases in the angiopoietin/TEK signaling pathway, autosomal dominant mutations in TEK have been identified in patients with primary congenital glaucoma [16] and congenital glaucoma associated with sclerocornea (specific variant not reported) [36]. The gene discussed is TEK; the disease is primary congenital glaucoma.